Long-term clinical outcomes of differentiated thyroid cancer patients with biochemical incomplete response after initial radioiodine therapy, a single-center, retrospective analysis
sTg≥50.0 ng/mL and T3b-T4 stage are robust, clinically accessible markers identifying PD among BIR patients, warranting intensified surveillance and potentially earlier therapeutic reconsideration.
Authors
- Xufu Wang (ORCID: https://orcid.org/0000-0002-0849-5429)
- Yutian Li (ORCID: https://orcid.org/0000-0002-5118-0916)
- Peihang Han
- Guohua Qin
- Congcong Wang
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Qingdao Women and Children's Hospital (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-01-28
- DOI
- https://doi.org/10.3389/fendo.2026.1770829
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shandong Province